Cannabotech Ltd. is a biomedical enterprise focused on developing advanced botanical solutions that integrate cannabinoids and medicinal mushrooms. The company crafts specialized products for various health applications, including integrative oncology treatments for conditions like pancreatic and breast cancer, alongside a range of personalized preventive medicine offerings such as CBD-infused skincare, oils, and dietary supplements. Leveraging its unique M²CBD formula, Cannabotech aims to deliver enhanced well-being through synergistic effects. The firm, based in Rishon LeZion, Israel, is expanding its global footprint with market activities across the UK, the United States, and Asia.